| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.79B | 10.04B | 8.39B | 6.61B | 5.75B | 4.76B |
| Gross Profit | 3.54B | 3.37B | 3.01B | 1.64B | 2.25B | 1.61B |
| EBITDA | 1.44B | 1.43B | 1.15B | -77.83M | 835.95M | 846.54M |
| Net Income | -2.72B | -538.08M | -2.70B | -422.30M | 557.39M | 495.74M |
Balance Sheet | ||||||
| Total Assets | 17.51B | 14.77B | 18.21B | 19.25B | 10.79B | 8.71B |
| Cash, Cash Equivalents and Short-Term Investments | 2.56B | 2.29B | 2.25B | 1.63B | 1.44B | 2.15B |
| Total Debt | 10.36B | 7.54B | 10.37B | 9.21B | 3.68B | 2.62B |
| Total Liabilities | 12.46B | 10.08B | 12.79B | 11.64B | 5.56B | 4.12B |
| Stockholders Equity | 5.05B | 4.69B | 5.41B | 7.61B | 5.23B | 4.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.20B | -775.41M | -2.63B | -1.60B | -346.36M |
| Operating Cash Flow | 0.00 | 2.85B | 885.16M | -953.77M | -119.25M | 443.38M |
| Investing Cash Flow | 0.00 | -683.92M | -1.54B | -6.14B | -1.73B | -849.16M |
| Financing Cash Flow | 0.00 | -2.25B | 1.28B | 7.30B | 1.12B | 1.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥258.28B | 27.62 | ― | 1.53% | 9.71% | 54.82% | |
76 Outperform | ¥518.06B | 54.86 | ― | 2.29% | 6.52% | -54.63% | |
74 Outperform | ¥142.05B | 8.22 | 8.07% | 2.64% | 81.06% | 65.92% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥61.86B | -97.38 | ― | 5.01% | -25.54% | -166.77% | |
60 Neutral | ¥57.00B | -109.65 | ― | ― | 19.60% | 80.57% | |
58 Neutral | ¥42.41B | 9.97 | ― | 0.91% | 11.44% | -4.29% |